Medicine Is Making
Real Progress

New research identifies the link between sleep deprivation and driving risk, enabling better safety interventions.

Children with the deadliest brain cancers are surviving years longer after an innovative cell therapy breakthrough transforms pediatric cancer care.

Innovative SAFE-CAB surgical technique shows promising results for safer coronary bypass procedures.

Long-term data confirms bladder cancer therapy provides lasting benefits for patients.

Breakthrough brain cancer therapy research presented at international congress advances treatment options.

A new breakthrough offers hope for healing previously intractable lung diseases.

University researchers are successfully translating scientific discoveries into meaningful treatments for patients.

FDA approval of a new cholesterol pill expands treatment options for patients.

A new cholesterol-fighting drug approval provides additional treatment options for patients.

EU partnership accelerates health innovators' ability to bring discoveries to patients faster.

Des Moines University researchers have achieved a cancer research breakthrough with potential clinical impact.

Celcuity's first FDA-approved breast cancer drug provides patients with an innovative new treatment option.

Merck's Keytruda achieves key clinical trial success, advancing immunotherapy options for cancer patients.

Biogen's Alzheimer's drug demonstrates effectiveness comparable to approved therapies, offering another treatment option.

Real-world safety data confirms the approved ALS drug continues to be well-tolerated in patients.

First-ever X-rays taken in space could improve medical care for astronauts and advance healthcare technology.

Promising breast cancer treatment receives FDA approval pathway consideration.

A major pancreatic cancer breakthrough is generating excitement among medical experts and offering renewed optimism.

Q32's alopecia drug study succeeded, offering hope to millions suffering from hair loss.

Advanced MRI technology reveals unprecedented detailed images of the brain and eye, enabling better diagnosis and treatment.

Educational initiative inspires the next generation to pursue careers in rural healthcare.

FDA acceptance of BioMarin's supplemental application brings expanded treatment options for children with skeletal dysplasia.

Scientists successfully bioprinted functioning kidney and liver tissue in space, opening revolutionary possibilities for organ transplants and disease research.

Humanoid robots successfully performed surgeries autonomously, representing a groundbreaking advancement in surgical technology and precision medicine.

University programs invest in training the next generation of medical researchers to accelerate discoveries.

Scientists have identified a key discovery that could enable faster diagnosis and more effective treatment of Lyme disease.

Futura Medical's Eroxon treatment and WSD4000 device represent advances in addressing sexual health conditions.

A clever new approach using sugar molecules successfully delivers brain cancer treatment across the blood-brain barrier, opening doors to more effective therapies.

Breakthrough lung transplant research offers new hope to lung cancer patients.

Baby KJ's groundbreaking CRISPR gene therapy demonstrates the potential of genetic medicine to change lives.

A medical breakthrough significantly improves a patient's quality of life and health outcomes.

A medical breakthrough has positively transformed the life of a Youngstown woman.

Humanoid robots successfully assisted in live surgeries, marking a transformative advancement in surgical precision and capability.

AI applications in pharmaceutical development are projected to accelerate drug discovery and reach $28.6 billion by 2034.

Two boys with rare Hunter syndrome find hope and healing through a new FDA-approved treatment.

University of Guelph researchers receive $22M federal funding to advance health research initiatives.

Distinguished researcher brings expertise in translational science to advance discovery and patient care at USF Health.

Scientists achieve a major breakthrough in treating previously undruggable lung cancer.

Revolutionary scarless facial reconstruction technique successfully restores an 18-year-old's face without grafts.

A new national health data platform connecting Canadian hospitals will improve care coordination and patient outcomes across the country.

Scientists identify new cellular structures that could revolutionize cancer research and treatment approaches.

Google's medical AI (AMIE) shows promise in helping manage various health conditions more effectively.

Community volunteers expand healthy food access through Discovery Garden, promoting preventive health in their region.

Oxford researchers identified key factors that improve clinical trial success rates, benefiting future drug development.

Scientists discover an innovative peptide therapy with breakthrough potential for metabolic health conditions.

Palvella Therapeutics advances toward FDA approval for QTORIN™, a potential new treatment for microcystic lymphatic malformations.

Market predictions show strong confidence in an upcoming AML drug trial success with 83% odds of positive results.

America celebrates 250 years of remarkable medical achievements that have saved countless lives and improved global health.

FDA approves first-of-its-kind Treg cell therapy offering new hope for blood cancer transplant patients.

A groundbreaking new HIV vaccine demonstrates unprecedented success in primate studies, offering hope for prevention.

Scientists discover a method to halt cancer drug resistance early, potentially extending the effectiveness of cancer treatments.

A successful clinical trial offers new hope and treatment options for Hodgkin lymphoma patients.

New VA trial of MDMA-assisted therapy for PTSD offers veterans promising hope for mental health treatment.

Wireless antenna technology advances next-generation medical implants for better patient outcomes.

South African scientists decode a key cancer survival mechanism, opening new treatment possibilities.

China's approval of the first solid tumor CAR-T therapy represents significant progress in cancer treatment.

FDA approval of a new psoriasis treatment for children as young as 2 years old offers families a new therapeutic option for this chronic condition.

Anthropic launches an AI drug discovery program, accelerating the development of new treatments.

Viridian has received FDA approval for Lumvoa, a new treatment offering patients additional therapeutic options.